These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38035462)

  • 1. SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses.
    Puhach O; Bellon M; Adea K; Bekliz M; Hosszu-Fellous K; Sattonnet P; Hulo N; Kaiser L; Eckerle I; Meyer B
    EBioMedicine; 2023 Dec; 98():104893. PubMed ID: 38035462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
    Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
    Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
    Liew F; Talwar S; Cross A; Willett BJ; Scott S; Logan N; Siggins MK; Swieboda D; Sidhu JK; Efstathiou C; Moore SC; Davis C; Mohamed N; Nunag J; King C; Thompson AAR; Rowland-Jones SL; Docherty AB; Chalmers JD; Ho LP; Horsley A; Raman B; Poinasamy K; Marks M; Kon OM; Howard L; Wootton DG; Dunachie S; Quint JK; Evans RA; Wain LV; Fontanella S; de Silva TI; Ho A; Harrison E; Baillie JK; Semple MG; Brightling C; Thwaites RS; Turtle L; Openshaw PJM; ;
    EBioMedicine; 2023 Jan; 87():104402. PubMed ID: 36543718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals.
    Butler SE; Crowley AR; Natarajan H; Xu S; Weiner JA; Bobak CA; Mattox DE; Lee J; Wieland-Alter W; Connor RI; Wright PF; Ackerman ME
    Front Immunol; 2020; 11():618685. PubMed ID: 33584712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response.
    Takamatsu Y; Omata K; Shimizu Y; Kinoshita-Iwamoto N; Terada M; Suzuki T; Morioka S; Uemura Y; Ohmagari N; Maeda K; Mitsuya H
    Microbiol Spectr; 2022 Dec; 10(6):e0271622. PubMed ID: 36219096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.
    Chan RWY; Liu S; Cheung JY; Tsun JGS; Chan KC; Chan KYY; Fung GPG; Li AM; Lam HS
    Front Immunol; 2021; 12():744887. PubMed ID: 34712232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination.
    Ishizaka A; Koga M; Mizutani T; Uraki R; Yamayoshi S; Iwatsuki-Horimoto K; Yamamoto S; Imai M; Tsutsumi T; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    Virol J; 2023 Jul; 20(1):146. PubMed ID: 37443091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of SARS-CoV-2-Specific Secretory IgA and Neutralizing Antibodies in the Nasal Secretions of Exposed Seronegative Individuals.
    Chwa JS; Kim M; Lee Y; Cheng WA; Shin Y; Jumarang J; Bender JM; Pannaraj PS
    Viruses; 2024 May; 16(6):. PubMed ID: 38932145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.
    Li D; Calderone R; Nsouli TM; Reznikov E; Bellanti JA
    Allergy Asthma Proc; 2022 Sep; 43(5):419-430. PubMed ID: 36065108
    [No Abstract]   [Full Text] [Related]  

  • 10. Mucosal antibody responses following Vaxzevria vaccination.
    Selva KJ; Ramanathan P; Haycroft ER; Tan CW; Wang LF; Downie LE; Davis SK; Purcell RA; Kent HE; Juno JA; Wheatley AK; Davenport MP; Kent SJ; Chung AW
    Immunol Cell Biol; 2023; 101(10):975-983. PubMed ID: 37670482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern.
    Lafon E; Jäger M; Bauer A; Reindl M; Bellmann-Weiler R; Wilflingseder D; Lass-Flörl C; Posch W
    J Allergy Clin Immunol; 2022 Apr; 149(4):1242-1252.e12. PubMed ID: 35093484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection.
    Sajadi MM; Myers A; Logue J; Saadat S; Shokatpour N; Quinn J; Newman M; Deming M; Rikhtegaran Tehrani Z; Magder LS; Karimi M; Abbasi A; Shlyak M; Baracco L; Frieman MB; Crotty S; Harris AD
    mSphere; 2022 Dec; 7(6):e0027922. PubMed ID: 36321826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
    Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
    mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection.
    Wright PF; Prevost-Reilly AC; Natarajan H; Brickley EB; Connor RI; Wieland-Alter WF; Miele AS; Weiner JA; Nerenz RD; Ackerman ME
    J Infect Dis; 2022 Sep; 226(7):1204-1214. PubMed ID: 35188974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination.
    Heaney CD; Hempel H; DeRosa KL; Pinto LA; Mantis NJ
    Clin Chem; 2024 Apr; 70(4):589-596. PubMed ID: 38039096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
    Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A; Sano K; Saito S; Shiwa-Sudo N; Nagata N; Tamura K; Suzuki R; Hasegawa H; Suzuki T
    Vaccine; 2022 Sep; 40(41):5892-5903. PubMed ID: 36064667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects.
    Martinuzzi E; Benzaquen J; Guerin O; Leroy S; Simon T; Ilie M; Hofman V; Allegra M; Tanga V; Michel E; Boutros J; Maniel C; Sicard A; Glaichenhaus N; Czerkinsky C; Blancou P; Hofman P; Marquette CH
    Clin Infect Dis; 2022 Dec; 75(12):2053-2059. PubMed ID: 35579991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
    Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Cordón PJ; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2022; 13():995235. PubMed ID: 36172368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.
    Bladh O; Aguilera K; Marking U; Kihlgren M; Greilert Norin N; Smed-Sörensen A; Sällberg Chen M; Klingström J; Blom K; Russell MW; Havervall S; Thålin C; Åberg M
    Front Immunol; 2024; 15():1346749. PubMed ID: 38558811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.